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Although animal studies have shown that the immunomodulator ipilimumab causes inflammation of the myocardium,
clinically significant myocarditis has been observed only infrequently. We report a case of suspected acute coronary
syndrome without a culprit lesion on cardiac angiography and takotsubo cardiomyopathy (TC)-like appearance on
echocardiography in a patient with metastatic melanoma who received four standard doses of ipilimumab.
Apical ballooning, hyperdynamic basal wall motion, systolic anterior motion of the mitral valve, and associated
severe left ventricular outflow tract obstruction were present. Restaging with positron emission tomography-computed
tomography done soon after discharge incidentally revealed increased fludeoxyglucose uptake in the apex. This case
illustrates that a TC-like syndrome might be caused by autoimmune myocarditis after ipilimumab treatment although
this was not biopsy-confirmed. Post-marketing surveillance should capture cardiac events occurring in patients treated
with ipilimumab to better document and clarify a relationship to the drug, and biopsies should be considered.
Physicians utilizing this novel agent should be aware of the potential for immune-related adverse events.
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Derived from Japanese word for octopus pot, typical
takotsubo cardiomyopathy (TC) presents clinically indis-
tinguishable from acute coronary syndrome, but systolic
apical ballooning of a hypo- or akinetic left ventricular
(LV) apex with hyperdynamic basal walls will be present
from the deleterious effects of a catecholamine surge. In
90% of cases, a clear emotional or physical stressor pre-
cedes the presentation, hence the term stress-induced car-
diomyopathy [1]. Acute increased adrenergic activity from
cocaine, pheochromocytoma, sub-arachnoid hemorrhage,
or trauma can precipitate TC via altered vascular tone
and/or direct toxicity. Patients experience typical chest pain
and may manifest heart failure or shock. Troponin release,
often small, and anterior ST segment elevations are usually
present. Angiography, per definition, should fail to reveal a
culprit lesion. In 16% of cases there is a pressure gradient
across a narrowed LV outflow tract, often associated with* Correspondence: bgeisler@post.harvard.edu
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port a case of “takotsubo cardiomyopathy-like” myocardial
dysfunction after ipilimumab treatment for metastatic ma-
lignant melanoma.Case presentation
An 83-year old woman with hypertension was diagnosed
with biopsy-proven vaginal melanoma four months prior
to admission. PET-CT showed invasive loco-regional dis-
ease and a three-millimeter nodule in the left upper lung
lobe. Attempted resection was complicated by positive
margins. Four cycles of ipilimumab (3 mg/kg every three
weeks), last dosed three weeks prior to hospitalization,
were administered. Radiotherapy was deferred. The pa-
tient had developed pruritus, lethargy, and malaise after
the third dose and diarrhea after the fourth dose of ipili-
mumab. These symptoms responded to short courses of
prednisone. Prior to admission, the patient experienced
two weeks of fairly continuous worsening substernal
chest pain and progressive dyspnea. On admission, she
denied acute emotional stress, illicit drug or herbalThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Ventriculogram during diastole (left) and systole (right). While the left ventricular apex in these two images appears nearly akinetic,
the remaining left ventricle is hyperkinetic.
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cardia at 110/minute and 1 millimeter ST elevations in
leads I, V2, and V3. The initial troponin-I level was 0.98
(normal <0.04) ng/ml, thyroid-stimulating hormone was
measured as 2.6 (0.4-4.0) mIU/L, and the erythrocyte sedi-
mentation rate was 65 (<20) mm/hour. A chest radiograph
revealed numerous round bilateral lung masses. Transtho-
racic echocardiography showed an akinetic apex, hyper-
kinetic base and septum, an ejection fraction of 50%, and
LV outflow tract obstruction with a peak gradient of
100 mmHg with SAM. Emergent cardiac angiography
demonstrated an isolated 30% proximal left anterior de-
scending artery stenosis without evidence of a thrombus.Figure 2 Coronal (left) and axial (right) PET/CT showing a focus of mi
left ventricular apex. Additional findings at the axial level through the ch
small right pleural effusion and a large hiatal hernia.No intervention was performed. Figure 1 displays the ven-
triculogram. The patient developed transient supraven-
tricular and ventricular tachycardia. A beta-blocker and
was started. On hospital day 3, the patient was asymptom-
atic and was transferred to acute cardiac rehabilitation.
18F-Fludeoxyglucose (FDG) PET-CT performed two days
later revealed focal FDG uptake in the patient’s ballooned
LV apex (Figure 2).
Discussion and conclusion
Drug-induced TC has been associated with direct-acting
sympathomimetic xenobiotics, causing myocardial dys-
function either directly, due to free radical formationldly increased FDG uptake corresponding to ballooning of the
est include FDG-avid metastatic lung nodules in the right upper lobe,
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atropine and adrenergic reuptake inhibitors may do the
same. Chemotherapeutics and monoclonal antibodies po-
tentially implicated have included 5-fluorouracil, rituxi-
mab, and vascular endothelial growth factor antagonists.
Postulated mechanisms include direct myocardial ische-
mia due to coronary vasospasm, toxic myocarditis from
impurities, upregulation of transforming growth factors
stimulating myocytal reticulin fiber growth, and increased
inflammatory cytokine levels [2,3].
Ipilimumab, a monoclonal antibody directed against
cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4),
leads to activated T-lymphocyte proliferation and results
in prolonged overall survival in metastatic melanoma [4].
Almost three quarters of patients on ipilimumab ex-
perience immune-related adverse events, most commonly
rash, pruritus, diarrhea, and colitis. One third of these are
severe, life-threatening, or disabling [5]. CTLA-4-deficient
mice succumb to myocarditis and pancreatitis character-
ized by lymphoproliferative infiltrates and granular tissue
formation [6,7]. Clinically significant myocarditis has been
identified in less than one percent of patients [8]. Although
the proposed Mayo Clinic criteria for TC precludes myo-
carditis [9], a TC-like appearance on echocardiography has
been reported in lymphocytic myocarditis without evi-
dence of a viral cause [10], suggesting that TC is a noso-
graphic entity with more than one etiology.
In the absence of a known stressor, considering the sub-
acute onset of symptoms, and supportive imaging, we
hypothesize that autoimmune myocarditis from ipilimumab-
related CTLA-4 inactivation could have accounted for our
patient’s presentation of a “takotsubo cardiomyopathy-like”
syndrome. Though the PET-CT was for restaging and not
protocolled as a cardiac study, focal FDG uptake in the LV
apex, corresponding to the akinetic myocardium, is dra-
matic. Focal uptake of FDG, representing enhanced meta-
bolic activity, may be due to microvascular or myocyte
damage, changes in fatty acid utilization, or a combination
[11]. As expected, most non-inflammatory TC cases in the
literature assessed with cardiac PET-CT show decreased
FDG uptake in the stunned areas [12,13]. However, a
recently reported case linked increased FDG uptake with
severely decreased fatty acid metabolism in an impaired,
inflamed myocardium [14]. When done early, a positive
PET-CT has a 100% specificity compared to endomyocar-
dial biopsy for acute myocarditis [15]. However, since no
biopsy was taken, a cardiac metastasis cannot be excluded
although most cases are clinically silent and cardiovascular
manifestations are rarely seen in isolation or as a present-
ing symptom; and cardiac lesions are usually multiple at
diagnosis [16].
Medline and Embase searches as well as a query to
the manufacturer of ipilimumab failed to reveal similar
cases. Therefore, to our knowledge, this might be the firstreported case of a “takotsubo cardiomyopathy-like” syn-
drome in a patient treated with ipilimumab. While no causal
relationship can be proven, post-marketing surveillance
should capture cases of ipilimumab cardiac toxicity and
physicians utilizing this novel agent should be aware of
this potential immune-related adverse event.
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